MedTrace Logo

Turkish Version of the Glaucoma Quality of Life-15 Questionnaire

NCT03967145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2020-04-08

No results posted yet for this study

Summary

Glaucoma is a disease with irreversible loss of visual field and optic neuropathy and is the most important cause of irreversible vision loss after cataract in the world. Although clinical evaluations reveal the level of glaucoma quantitatively, it is necessary to evaluate the impact of this pathology on daily functions and quality of life with a holistic perspective and to provide appropriate advice to patients according to the information obtained. Glaucoma Quality of Life -15 Questionnaire (GQoL-15) was developed by Nelson et al. in 2003 to evaluate the quality of life of glaucoma patients. The aim of this study is to translate GQoL-15 into Turkish and evaluate its test-retest reliability for Turkish-speaking population.

Conditions

Interventions

BEHAVIORAL

Determining quality of life

Quality of Life

Sponsors & Collaborators

  • Haydarpasa Numune Training and Research Hospital

    collaborator OTHER

  • Acibadem University

    lead OTHER

Principal Investigators

  • Özgül Öztürk · Acibadem University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-27
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967145 on ClinicalTrials.gov